<ѻýҕl>PSA Nadir 6 Months After Primary RT Correlates With Prostate Cancer Outcomesѻýҕl> Or does it? Editorial questions prognostic, predictive value in contemporary practice May 22, 2024
<ѻýҕl>Lack of Clinical Trial Availability Tied to Worse Prostate Cancer Mortalityѻýҕl> "It's a trend we really don't want to see," researcher says May 06, 2024
<ѻýҕl>No PSA Recurrence at 24 Months With Apalutamide Plus ADT After Radical Prostatectomyѻýҕl> Biochemical control maintained despite high rates of testosterone recovery May 05, 2024
<ѻýҕl>HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancerѻýҕl> Better urinary and erectile function outcomes with high-intensity focused ultrasound May 04, 2024
<ѻýҕl>Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancyѻýҕl> Risk for any second malignancy, death from any second malignancy not higher versus prostatectomy Apr 23, 2024
<ѻýҕl>Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RTѻýҕl> No difference in freedom from distant metastasis or overall survival at 10 years Apr 19, 2024
<ѻýҕl>Urine Test Accurately Detected High-Grade Prostate Cancerѻýҕl> Researchers say use of the test could substantially reduce unnecessary biopsies Apr 18, 2024
<ѻýҕl>Could Francis Collins's Prostate Cancer Story Deter Men From Active Surveillance?ѻýҕl> Experts suggest his apparent situation is rare Apr 17, 2024
<ѻýҕl>Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosisѻýҕl> Former NIH director said he went public to "share lifesaving information" Apr 12, 2024
<ѻýҕl>Novel PARP1 Inhibitor Shows Promise in Breast Cancerѻýҕl> The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study Apr 09, 2024
<ѻýҕl>Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?ѻýҕl> Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
<ѻýҕl>PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screeningѻýҕl> Early results suggest approach reduces overdiagnosis while better detecting high-grade cancer Apr 06, 2024
<ѻýҕl>Bracing for a Surge in Prostate Cancer Diagnosesѻýҕl> Report: Demographic changes will lead to a doubling of cases, 85% increase in mortality by 2040 Apr 05, 2024
<ѻýҕl>Some Cancer Patients Can Find It Hard to Tell Family and Friendsѻýҕl> Recent high-profile examples highlight this reluctance Mar 31, 2024
<ѻýҕl>Mutation Linked to Increased Risk of Prostate Cancer Mortalityѻýҕl> Cancer-specific mortality twice as high in patients with specific genotype for HSD3B1 allele Mar 20, 2024
<ѻýҕl>Study Tests Office-Based Transperineal Approach to Prostate Biopsiesѻýҕl> Antibiotic-free option resulted in zero infections in randomized trial Feb 29, 2024 video
<ѻýҕl>Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemicѻýҕl> Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
<ѻýҕl>Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPCѻýҕl> A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD Feb 22, 2024 video
<ѻýҕl>Radioligand Therapy Continues to Show Promise for Metastatic CRPCѻýҕl> Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients Feb 16, 2024
<ѻýҕl>More Data Support Olaparib-Abiraterone in BRCA-Mutant Prostate Cancerѻýҕl> BRCAAway trial confirms role of combination in first-line setting Feb 15, 2024 video
<ѻýҕl>Improved Fitness May Reduce Prostate Cancer Riskѻýҕl> Observational study finds reduced incidence in men who increased their cardiorespiratory fitness Feb 01, 2024
<ѻýҕl>Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Careѻýҕl> Study looked at how three recommendations changed primary care decisions Jan 29, 2024
<ѻýҕl>More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effectsѻýҕl> More fatigue, depression, worse reaction time with enzalutamide as compared with abiraterone Jan 29, 2024
<ѻýҕl>Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testingѻýҕl> Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity Jan 28, 2024
<ѻýҕl>Cabozantinib Plus Atezolizumab Delays Progression in mCRPCѻýҕl> Combination improved PFS versus more hormonal therapy, but control arm questioned Jan 26, 2024
<ѻýҕl>Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Aloneѻýҕl> In small first-line trial, PFS more than doubled with combination Jan 26, 2024
<ѻýҕl>Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancerѻýҕl> OS, PFS, cancer-specific survival all improved, with no increase in toxicity Jan 26, 2024
<ѻýҕl>Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancerѻýҕl> Intensification should be considered for high-risk patients, researchers say Jan 24, 2024
<ѻýҕl>I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quietѻýҕl> But opening up can help reduce stigma and inform the public Jan 18, 2024
<ѻýҕl>Surgeon Dies in Plane Crash; Austin Released From Hospital; Animal Pandemic Spreadsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Jan 16, 2024
<ѻýҕl>No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsyѻýҕl> No effect on anxiety but significantly less patient-rated pain Jan 12, 2024
<ѻýҕl>Trump-Era Conscience Rule Rescinded; Lloyd Austin's Cancer; Sinead O'Connor's Deathѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Jan 10, 2024
<ѻýҕl>More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effectsѻýҕl> Meta-analysis shows increased risk of dementia, Parkinson's, depression Jan 09, 2024
<ѻýҕl>Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Riskѻýҕl> No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
<ѻýҕl>TULSA Effective in Controlling Prostate Cancer Long-Termѻýҕl> At 5 years, median PSA was reduced by 90% Dec 05, 2023
<ѻýҕl>Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomyѻýҕl> Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
<ѻýҕl>Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparitiesѻýҕl> A "local heroes effect" can better reach communities of color Nov 09, 2023
<ѻýҕl>Transitioning Cancer Survivors Away From Oncologic Careѻýҕl> It's time for a new model of care Nov 03, 2023
<ѻýҕl>Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPCѻýҕl> Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
<ѻýҕl>Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPCѻýҕl> Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023